I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Use of subcutaneous tocilizumab to prepare intravenous solu..:
Navas, Natalia
;
Hermosilla, Jesús
;
Torrente-López, Anabel
...
https://www.sciencedirect.com/science/article/pii/S2095177920304895?via%3Dihub. , 2020
Link:
http://hdl.handle.net/10668/3505
RT Journal T1
Use of subcutaneous tocilizumab to prepare intravenous solutions for COVID-19 emergency shortage: Comparative analytical study of physicochemical quality attributes
UL https://suche.suub.uni-bremen.de/peid=base-ftsspa:oai:www.repositoriosalud.es:10668_3505&Exemplar=1&LAN=DE A1 Navas, Natalia A1 Hermosilla, Jesús A1 Torrente-López, Anabel A1 Hernández-Jiménez, José A1 Cabeza, Jose A1 Pérez-Robles, Raquel A1 Salmerón-García, Antonio PB Xi'an Jiaotong University. Editor comercial: Elsevier B.V. YR 2020 K1 COVID-19 K1 Tocilizumab K1 Critical quality attributes K1 IV and SC medicines K1 Síndrome de liberación de citoquinas K1 SARS-CoV-2 K1 Preparaciones farmacéuticas K1 Cytokine release syndrome K1 Medical Subject Headings::Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humans K1 Medical Subject Headings::Chemicals and Drugs::Amino Acids K1 Peptides K1 and Proteins::Proteins::Blood Proteins::Immunoproteins::Immunoglobulins::Antibodies::Antibodies K1 Monoclonal::Antibodies K1 Monoclonal K1 Humanized K1 and Proteins::Proteins::Intercellular Signaling Peptides and Proteins::Cytokines::Interleukins::Interleukin-6 K1 Medical Subject Headings::Analytical K1 Diagnostic and Therapeutic Techniques and Equipment::Therapeutics::Drug Therapy::Drug Prescriptions::Off-Label Use K1 Medical Subject Headings::Health Care::Environment and Public Health::Public Health::Disease Outbreaks::Epidemics::Pandemics K1 Medical Subject Headings::Health Care::Environment and Public Health::Public Health K1 Diagnostic and Therapeutic Techniques and Equipment::Equipment and Supplies::Syringes K1 Medical Subject Headings::Health Care::Health Care Facilities K1 Manpower K1 and Services::Health Facilities::Hospitals K1 Medical Subject Headings::Chemicals and Drugs::Pharmaceutical Preparations JF https://www.sciencedirect.com/science/article/pii/S2095177920304895?via%3Dihub LK http://hdl.handle.net/10668/3505 DO http://hdl.handle.net/10668/3505 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)